TELA Bio (TELA) Competitors $1.62 +0.03 (+1.89%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.64 +0.01 (+0.93%) As of 09/19/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TELA vs. OM, TLSI, MGRM, SI, INGN, STIM, NNOX, INFU, CVRX, and ELMDShould you be buying TELA Bio stock or one of its competitors? The main competitors of TELA Bio include Outset Medical (OM), TriSalus Life Sciences (TLSI), Monogram Orthopaedics (MGRM), Shoulder Innovations (SI), Inogen (INGN), Neuronetics (STIM), Nano-X Imaging (NNOX), InfuSystem (INFU), CVRx (CVRX), and Electromed (ELMD). These companies are all part of the "medical equipment" industry. TELA Bio vs. Its Competitors Outset Medical TriSalus Life Sciences Monogram Orthopaedics Shoulder Innovations Inogen Neuronetics Nano-X Imaging InfuSystem CVRx Electromed Outset Medical (NASDAQ:OM) and TELA Bio (NASDAQ:TELA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, risk, earnings, dividends and media sentiment. Which has more volatility and risk, OM or TELA? Outset Medical has a beta of 2.13, indicating that its stock price is 113% more volatile than the S&P 500. Comparatively, TELA Bio has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Is OM or TELA more profitable? TELA Bio has a net margin of -54.12% compared to Outset Medical's net margin of -82.06%. Outset Medical's return on equity of -97.17% beat TELA Bio's return on equity.Company Net Margins Return on Equity Return on Assets Outset Medical-82.06% -97.17% -32.84% TELA Bio -54.12%-329.48%-57.34% Which has higher earnings & valuation, OM or TELA? TELA Bio has lower revenue, but higher earnings than Outset Medical. TELA Bio is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOutset Medical$113.69M2.22-$127.98M-$20.29-0.70TELA Bio$69.30M0.93-$37.84M-$1.12-1.45 Do institutionals & insiders have more ownership in OM or TELA? 94.4% of TELA Bio shares are owned by institutional investors. 2.4% of Outset Medical shares are owned by insiders. Comparatively, 4.7% of TELA Bio shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts rate OM or TELA? Outset Medical currently has a consensus target price of $24.67, indicating a potential upside of 73.95%. TELA Bio has a consensus target price of $4.50, indicating a potential upside of 177.78%. Given TELA Bio's higher possible upside, analysts plainly believe TELA Bio is more favorable than Outset Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Outset Medical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.00TELA Bio 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media refer more to OM or TELA? In the previous week, Outset Medical had 1 more articles in the media than TELA Bio. MarketBeat recorded 2 mentions for Outset Medical and 1 mentions for TELA Bio. Outset Medical's average media sentiment score of 1.77 beat TELA Bio's score of 0.68 indicating that Outset Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Outset Medical 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive TELA Bio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryOutset Medical beats TELA Bio on 10 of the 16 factors compared between the two stocks. Get TELA Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TELA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TELA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TELA vs. The Competition Export to ExcelMetricTELA BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$62.99M$3.16B$5.79B$10.40BDividend YieldN/A2.37%5.63%4.60%P/E Ratio-1.4520.5276.4826.75Price / Sales0.93446.54531.72124.23Price / CashN/A46.0037.9261.55Price / Book2.259.6613.726.40Net Income-$37.84M-$53.02M$3.29B$271.62M7 Day Performance2.53%3.12%2.66%3.46%1 Month Performance-4.14%7.57%6.02%9.87%1 Year Performance-37.45%11.17%80.02%28.45% TELA Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TELATELA Bio2.4466 of 5 stars$1.62+1.9%$4.50+177.8%-39.6%$62.99M$69.30M-1.45120OMOutset Medical2.2126 of 5 stars$13.81-1.4%$24.67+78.6%+59.1%$248.90M$113.69M-0.68520Positive NewsTLSITriSalus Life Sciences2.3596 of 5 stars$5.01+0.4%$10.75+114.6%+6.8%$248.84M$29.43M-4.25106News CoverageAnalyst UpgradeMGRMMonogram Orthopaedics1.6591 of 5 stars$5.75+0.7%$5.40-6.1%+105.6%$232.01MN/A-11.5028News CoveragePositive NewsShort Interest ↓SIShoulder Innovations3.6136 of 5 stars$16.03+7.9%$19.60+22.3%N/A$226.14MN/A-0.5461Positive NewsINGNInogen4.0516 of 5 stars$8.45+4.2%$11.00+30.2%-19.4%$219.29M$343.47M-7.971,030Positive NewsSTIMNeuronetics1.4727 of 5 stars$3.37+4.3%$7.00+107.7%+193.4%$213.58M$74.89M-2.98180Positive NewsNNOXNano-X Imaging2.7588 of 5 stars$4.02+8.9%$8.50+111.4%-37.3%$213.21M$11.28M-4.47190News CoveragePositive NewsAnalyst ForecastINFUInfuSystem2.3807 of 5 stars$10.26+1.0%$12.50+21.8%+58.5%$209.57M$139.89M171.03410CVRXCVRx2.4296 of 5 stars$7.95+1.7%$14.00+76.1%-22.5%$204.51M$51.29M-3.79160ELMDElectromed3.9911 of 5 stars$24.96+2.0%$36.25+45.2%+20.9%$204.31M$64M33.28160 Related Companies and Tools Related Companies Outset Medical Competitors TriSalus Life Sciences Competitors Monogram Orthopaedics Competitors Shoulder Innovations Competitors Inogen Competitors Neuronetics Competitors Nano-X Imaging Competitors InfuSystem Competitors CVRx Competitors Electromed Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TELA) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TELA Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TELA Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
